Product Reports Resources Pricing Login Book a demo

Foundation Medicine

Biotech & Life Sciences · Boston, United States · Founded 2010 · IPO 2013

Transformation in cancer care, where each patient’s treatment is informed by a deep understanding of the molecular changes that contribute to their disease

Valuation $5.30B
Revenue $153M
Power Law Unicorn$1–10B valuation tier
Featured in
News Roche pays up to $595M for cancer detection startup SAGA Diagnostics Apr 16, 2026

Investors

11 investors on Foundation Medicine's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 2 investors entered at this stage
Kleiner Perkins
Third Rock Ventures
Series B+ 9 investors entered at this stage
Harvard Medical School
Redmile Group
Harvard University
Bill Gates
Casdin Capital
Roche Venture Fund
Broad Institute
Evan Jones
Dana-Farber Cancer Institute

Global footprint

Where Foundation Medicine has talent and traffic

Workforce by country
🇺🇸 United States · Boston HQ
Book a demo for the full country breakdown
Web traffic by country
65K monthly visits
across markets
🇺🇸 United States60.3%
🇺🇦 Ukraine16.8%
🇨🇦 Canada4.3%
🏳️ Korea3.1%
🏳️ Republic of3.1%
Top 5 markets shown

Talent graph

The shape of Foundation Medicine's talent

Dealroom maps Foundation Medicine's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Foundation Medicine's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Patent intelligence

$92M patent portfolio · 140 active families

Estimated portfolio value
$92M
1.7% of market cap · 8.6× smaller than top peer BioNTech ($788M)
140 active patent families
Where Foundation Medicine innovates BioinformaticsCancer researchCarcinosisComputational biologyData mining

Where Foundation Medicine concentrates vs peers

Each axis is a top-10 topic across Foundation Medicine and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Foundation Medicine's 3 investments and acquisitions.

Every disclosed deal where Foundation Medicine appeared as a backer or acquirer, 2016–2026. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

3 deals across Foundation Medicine's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        Foundation Medicine's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        3 of 3 deals

        Market sentiment

        What the market is saying about Foundation Medicine

        An AI-synthesized read of the highest-engagement posts about Foundation Medicine on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Foundation Medicine on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles